(Q1)Mar 31, 2024 | (FY)Dec 31, 2022 | (FY)Dec 31, 2021 | |
---|---|---|---|
Operating Cash Flow (Indirect Method) | |||
Cash flow from continuing operating activities | 579.29K | -79.60%-825.81K | -459.8K |
Net income from continuing operations | --29.17K | -432.73%-925.75K | --278.23K |
Operating gains losses | ---- | --64.73K | ---- |
Depreciation and amortization | --618 | ---- | ---- |
Other non cash items | --7K | 112.00%15.96K | ---133.08K |
Change In working capital | --533.3K | 100.69%4.15K | ---604.96K |
-Change in receivables | ---8.12K | -131.77%-118.49K | --372.95K |
-Change in prepaid assets | ---22.41K | 105.45%5.56K | ---101.94K |
-Change in payables and accrued expense | ---5.18K | 711.26%664.96K | ---108.79K |
-Change in other working capital | --569K | 28.58%-547.88K | ---767.17K |
Cash from discontinued investing activities | |||
Operating cash flow | --579.29K | -79.59%-825.78K | ---459.8K |
Investing cash flow | |||
Cash flow from continuing investing activities | -8.74K | ||
Net PPE purchase and sale | ---8.74K | ---- | ---- |
Cash from discontinued investing activities | |||
Investing cash flow | ---8.74K | ---- | ---- |
Financing cash flow | |||
Cash flow from continuing financing activities | 0 | 2,190.32%710K | 31K |
Net issuance payments of debt | --0 | --710K | --0 |
Net common stock issuance | ---- | --0 | --31K |
Cash from discontinued financing activities | |||
Financing cash flow | --0 | 2,190.32%710K | --31K |
Net cash flow | |||
Beginning cash position | --118.73K | -55.31%346.44K | --775.24K |
Current changes in cash | --570.55K | 73.00%-115.78K | ---428.8K |
End cash Position | --689.28K | -33.42%230.66K | --346.44K |
Free cash flow | --570.55K | -79.59%-825.78K | ---459.8K |
Currency Unit | USD | USD | USD |
Accounting Standards | US-GAAP | US-GAAP | US-GAAP |
No Data
No Data